Skip to main content
Log in

Tea polyphenols exerts anti-hepatitis B virus effects in a stably HBV-transfected cell line

  • Published:
Journal of Huazhong University of Science and Technology [Medical Sciences] Aims and scope Submit manuscript

Summary

In this study, the anti-HBV effects of tea polyphenols (TP) were examined. After cells were exposed to TP for 3, 6, 9 days, amounts of HBsAg, HBeAg and HBV-DNA released into the supernatant of the cultured HepG2 2.2.15 cells were detected. TP, to some extent, inhibited the secretion of HBsAg and strongly suppressed the secretion of HBeAg in a dose-dependent (P<0.01) and time-dependent manner, with 50% maximal inhibitory concentration (IC50) value being 7.34 μg/mL on the 9th day, but the time-dependence was not significant (P=0.051). Expression of HBV-DNA in the supernatant of the cell culture also was significantly decreased in a dose-dependent fashion (P<0.01). The IC50 of TP in inhibiting HBV DNA was 2.54 μg/mL. It concluded that TP possessed potential anti-HBV effects and may be used as a treatment alternative for HBV infection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. World Health Organization. Hepatitis B fact sheet WHO/204. Geneva: World Health Organization, October 2000. [Accessed February 10, 2006, http://www.who.int/mediacentre/factsheets/fs204/en

    Google Scholar 

  2. Chisari FV. Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B. Am J Pathol, 2000, 156(4):1117–1132

    PubMed  CAS  Google Scholar 

  3. Merle P, Trepo C. Therapeutic management of hepatitis B-related cirrhosis. J Virol Hepatitis, 2001, 8(6):391–399

    Article  CAS  Google Scholar 

  4. Benhamou Y, Bochet M, Thibault V, et al. Safety and efficacy of adefovir dipivoxil in patents co-infected with HIV and lamivudine-resistant hepatitis B virus: an open label pilot study. Lancet, 2001, 358(9283):718–723

    Article  PubMed  CAS  Google Scholar 

  5. Manesis EK, Hadziyannis SJ. Interferon α treatment and retreatment of hepatitis be antigen-negative chronic hepatitis B. Gastroenterology, 2001, 121(1):101–109

    Article  PubMed  CAS  Google Scholar 

  6. Kwon DH, Kwon HY, Kim HJ et al. Inhibition of hepatitis B virus by an aqueous extract of Agrimonia eupatoria L. Phytother Res, 2005, 19(4):355–358

    Article  PubMed  Google Scholar 

  7. Yang CS, Lambert JD, Hou Z, et al. Molecular targets for the cancer preventive activity of tea polyphenols. Mol Carcinog, 2006, 45(6):431–435

    Article  PubMed  CAS  Google Scholar 

  8. Kawai K, Tsuno NH, Kitayama J, et al. Epigallocatechin gallate, the main component of tea polyphenol, binds to CD4 and interferes with gp120 binding. J Allergy Clin Immunol, 2003, 112(5):951–957

    Article  PubMed  CAS  Google Scholar 

  9. Katiyar SK. UV-induced immune suppression and photo-carcinogenesis: chemoprevention by dietary botanical agents. Cancer Lett, 2007, 255(1):1–11

    Article  PubMed  CAS  Google Scholar 

  10. Lambert JD, Hong J, Yang GY, et al. Inhibition of carcinogenesis by polyphenols: evidence from laboratory investigations. Am J Clin Nutr, 2005, 81(1):S284–S291

    Google Scholar 

  11. Chen H, Zhang M, Qu Z, et al. Compositional analysis and preliminary toxicological evaluation of a tea polysaccharide conjugate. J Agric Food Chem, 2007, 55(6):2256–2260

    Article  PubMed  CAS  Google Scholar 

  12. Sells MA, Chen ML, Acs G et al. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus. Proc Natl Acad Sci USA, 1987, 84(4):1005–1009

    Article  PubMed  CAS  Google Scholar 

  13. Block TM, Lu X, Platt FM, et al. Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin. Proc Natl Acad Sci USA, 1994, 91(6):2235–2239

    Article  PubMed  CAS  Google Scholar 

  14. Chang JS, Liu HW, Wang KC, et al. Ethanol extract of olygonum cuspidatum inhibits hepatitis B virus in a stable HBV-producing cell line. Antiviral Res, 2005, 66(1):29–34

    Article  PubMed  CAS  Google Scholar 

  15. Carmichael J, DeGraff WG, Gazdar AF, et al. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res, 1987, 47(4):5875–5879

    PubMed  Google Scholar 

  16. Li CQ, Zhu YT, Zhang FX, et al. Anti-HBV effect of liposome-encapsulated matrine in vitro and in vivo. World J Gastroenterol, 2005, 11(3):426–428

    PubMed  CAS  Google Scholar 

  17. Lok AS. The Maze of Treatments for Hepatitis B. N Engl J Med, 2005, 352(26):2743–2746

    Article  PubMed  CAS  Google Scholar 

  18. Seef LB, Lindsay KL, Bacon BR, et al. Complementary and alternative medicine in chronic liver disease. Hepatology, 2001, 34(3):595–603

    Article  Google Scholar 

  19. Dhiman RK, Chawla YK. Herbal medicines for liver diseases. Dig Dis Sci, 2005, 50(10):1807–1812

    Article  PubMed  CAS  Google Scholar 

  20. Yang CS, Landau JM, Huang MT, et al. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr, 2001, 21:381–406

    Article  PubMed  CAS  Google Scholar 

  21. Mukhtar H, Ahmad N. Tea polyphenols: prevention of cancer and optimizing health. Am J Clin Nutr, 2000, 71(6 Suppl):1698S–1702S

    PubMed  CAS  Google Scholar 

  22. Garbisa S, Sartor L, Biggin S, et al. Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate. Cancer, 2001, 91(4):822–832

    Article  PubMed  CAS  Google Scholar 

  23. Suganuma M, Okabe S, Kai Y, et al. Synergistic effects of (−)-epigallocatechin gallate with (−)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9. Cancer Res, 1999, 59(1):44–47

    PubMed  CAS  Google Scholar 

  24. Nakane H, Ono K. Differential inhibition of HIV-reverse transcriptase and various DNA and RNA polymerases by some catechin derivatives. Nucleic Acids Symp Ser, 1989, (21):115–116

  25. Harada S, Haneda E, Maekawa T, et al. Casein kinase II (CK-II)-mediated stimulation of HIV-1 reverse transcriptase activity and characterization of selective inhibitors in vitro. Biol Pharm Bull, 1999, 22(10):1122–1126

    PubMed  CAS  Google Scholar 

  26. Yamaguchi K, Honda M, Ikigai H, et al. Inhibitory effects of (−)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1). Antiviral Res, 2002, 53(1):19–34

    Article  PubMed  CAS  Google Scholar 

  27. Fassina G, Buffa A, Benelli R, et al. Polyphenolic antioxidant (−)-epigallocatechin-3-gallate from green tea as a candidate anti-HIV agent. AIDS, 2002, 16(6):939–941

    Article  PubMed  CAS  Google Scholar 

  28. Singh R, Ahmed S, Islam N, et al. Epigallocatechin-3-gallate inhibits interleukin-1beta-induced expression of nitric oxide synthase and production of nitric oxide in human chondrocytes: suppression of nuclear factor kappaB activation by degradation of the inhibitor of nuclear factor kappaB. Arthritis Rheum, 2002, 46(8):2079–2086

    Article  PubMed  CAS  Google Scholar 

  29. Kawai K, Tsuno NH, Kitayama J, et al. Epigallocatechin gallate induces apoptosis of monocytes. J Allergy Clin Immunol, 2005, 115(1):186–191

    Article  PubMed  CAS  Google Scholar 

  30. Kawai K, Tsuno NH, Kitayama J, et al. Epigallocatechin gallate attenuates adhesion and migration of CD8+ T cells by binding to CD11b. J Allergy Clin Immunol, 2004, 113(6):1211–1217

    Article  PubMed  CAS  Google Scholar 

  31. Chen JH, Tipoe GL, Liong EC, et al. Green tea polyphenols prevent toxin-induced hepatotoxicity in mice by down-regulating inducible nitric oxide-derived prooxidants. Am J Clin Nutr, 2004, 80(3):742–751

    PubMed  CAS  Google Scholar 

  32. Zhen MC, Wang Q, Huang XH, et al. Green tea polyphenol epigallocatechin-3-gallate inhibits oxidative damage and preventive effects on carbon tetrachloride-induced hepatic fibrosis. J Nutr Biochem, 2007, 18(12):795–805

    Article  PubMed  CAS  Google Scholar 

  33. Higashi N, Kohjima M, Fukushima M, et al. Epigallocatechin-3-gallate, a green-tea polyphenol, suppresses Rho signaling in TWNT-4 human hepatic stellate cells. J Lab Clin Med, 2005, 145(6):316–322

    Article  PubMed  CAS  Google Scholar 

  34. Cooper R, Morre DJ, Morre DM, et al. Medicinal benefits of green tea. Part I. Review of noncancer health benefits (review). J Altern Complement Med, 2005, 11(3):521–528

    Article  PubMed  Google Scholar 

  35. Pugh JC, Bassendine MF. Molecular biology of hepadnavirus replication. Br Med Bull, 1990, 46(2):329–353

    PubMed  CAS  Google Scholar 

  36. Lambert JD, Hong J, Yang GY, et al. Inhibition of carcinogenesis by polyphenols: evidence from laboratory investigations. Am J Clin Nutr, 2005, 81(1 Suppl):284S–291S

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

The project was supported by a grant from the R&D Department of Hubei Province (No. 2007B07).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ye, P., Zhang, S., Zhao, L. et al. Tea polyphenols exerts anti-hepatitis B virus effects in a stably HBV-transfected cell line. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 29, 169–172 (2009). https://doi.org/10.1007/s11596-009-0206-1

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11596-009-0206-1

Key words

Navigation